Stock Research: AbbVie

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

AbbVie

NYSE:ABBV US00287Y1091
44
  • Value
    18
  • Growth
    68
  • Safety
    Safety
    55
  • Combined
    51
  • Sentiment
    42
  • 360° View
    360° View
    44
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

AbbVie Inc. is a global biopharmaceutical company focused on research, development, manufacturing, and commercialization of medicines and therapies. Key areas include Immunology, Oncology, Aesthetics, Neuroscience, and Eye Care. In the last fiscal year, the company had a market cap of $329,240 million, profits of $39,430 million, revenue of $56,334 million, and 55000 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 44 (better than 44% compared with alternatives), overall professional sentiment and financial characteristics for the stock AbbVie are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for AbbVie. The consolidated Value Rank has an attractive rank of 55, which means that the share price of AbbVie is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 55% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 68, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 42. Professional investors are more confident in 58% other stocks. Worryingly, the company has risky financing, with a Safety rank of 18. This means 82% of comparable companies have a safer financing structure than AbbVie. ...read more

more
Index
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
55 72 n/a n/a
Growth
68 35 n/a n/a
Safety
Safety
18 36 n/a n/a
Sentiment
42 96 n/a n/a
360° View
360° View
44 75 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
34 35 n/a n/a
Opinions Change
5 70 n/a n/a
Pro Holdings
n/a 94 n/a n/a
Market Pulse
61 85 n/a n/a
Sentiment
42 96 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
55 72 n/a n/a
Growth
68 35 n/a n/a
Safety Safety
18 36 n/a n/a
Combined
51 43 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
40 61 n/a n/a
Price vs. Earnings (P/E)
39 28 n/a n/a
Price vs. Book (P/B)
1 1 n/a n/a
Dividend Yield
90 100 n/a n/a
Value
55 72 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
51 35 n/a n/a
Profit Growth
39 53 n/a n/a
Capital Growth
79 33 n/a n/a
Stock Returns
60 59 n/a n/a
Growth
68 35 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
9 9 n/a n/a
Refinancing
4 5 n/a n/a
Liquidity
71 92 n/a n/a
Safety Safety
18 36 n/a n/a

Similar Stocks

Discover high‑ranked alternatives to AbbVie and broaden your portfolio horizons.

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

TEGNA

NYSE:TGNA
Country: USA
Industry: Broadcasting
Size: Medium
Full Stock Analysis

PriceSmart

NasdaqGS:PSMT
Country: USA
Industry: Hypermarkets, Super Centers
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.